Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab

NCT02029326 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02029326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02029326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
February 1, 2010
Completion date
August 26, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer